OSAMU KAMINUMA

Last Updated :2023/02/02

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Professor
E-mail
okamihiroshima-u.ac.jp
Self-introduction
Development of mouse models useful to create novel treatments for various diseases

Basic Information

Academic Degrees

  • The University of Tokyo

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences : Program of Biomedical Science
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Radiation Biology and Medicine

Research Fields

  • Agricultural sciences;Animal life science;Veterinary medical science
  • Medicine,dentistry, and pharmacy;Basic medicine;Immunology
  • Agricultural sciences;Boundary agriculture;Applied molecular and cellular biology
  • Medicine,dentistry, and pharmacy;Pharmacy;Biological pharmacy

Research Keywords

  • Experimental Animals, Immunology, Genetic modification, Somatic cell clone, Artificial chromosome, T cell, Allergy

Affiliated Academic Societies

  • Japanese Association for Laboratory Animal Science
  • Japanese Society for Immunology
  • Japanese Society of Allergology
  • The Japanese Biochemical Society
  • The Japanese Pharmacological Society
  • The Workshop on Eosinophils in Allergy and Related Diseases
  • The Japanese Society of Veterinary Science
  • Japanese Association for Laboratory Animal Medicine
  • Japan Allergy Foundation
  • The American Association of Immunologists
  • The American Society for Biochemistry and Molecular Biology

Educational Activity

Course in Charge

  1. 2022, Liberal Arts Education Program1, 1Term, Foundation biology for life science
  2. 2022, Liberal Arts Education Program1, 1Term, Foundation biology for life science
  3. 2022, Undergraduate Education, Intensive, Practice for medical research
  4. 2022, Undergraduate Education, 2Term, Outline of Immunology
  5. 2022, Graduate Education (Master's Program) , First Semester, Seminar
  6. 2022, Graduate Education (Master's Program) , Second Semester, Seminar
  7. 2022, Graduate Education (Master's Program) , First Semester, Research
  8. 2022, Graduate Education (Master's Program) , Second Semester, Research
  9. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar
  10. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar
  11. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research
  12. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research
  13. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Disease Model
  14. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Disease Model
  15. 2022, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Disease Model
  16. 2022, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Disease Model
  17. 2022, Graduate Education (Doctoral Program) , Second Semester, Introduction to Radiation Biology

Research Activities

Academic Papers

  1. Suppressive Effect of Lactococcus lactis subsp. cremoris YRC3780 on a Murine Model of Japanese Cedar Pollinosis., Pathogens, 11, 1347, 202211
  2. Re-evaluation of over-the-counter histamine H1-receptor antagonists based on their effects on murine models of allergen-induced nasal hyperresponsiveness, Journal of Pharmacological Sciences, 150(4), 275-278, 202210
  3. BACH1 promotes clear cell renal cell carcinoma progression via upregulating oxidative stress-related tumorigenicity., Cancer Science, 202209
  4. DDX41 expression is associated with tumor necrosis in clear cell renal cell carcinoma and in cooperation with VHL loss leads to worse prognosis., Urologic Oncology, 40(10), 456.e9-456.e18, 202207
  5. Th17-Dependent Nasal Hyperresponsiveness Is Mitigated by Steroid Treatment, BIOMOLECULES, 12(5), 202205
  6. Regulation of Th2 responses by Lactococcus lactis subsp. cremoris YRC3780 alleviates DNCB-induced atopic dermatitis in the mouse model, JOURNAL OF FUNCTIONAL FOODS, 94, 202207
  7. Therapeutic Potential for Intractable Asthma by Targeting L-Type Amino Acid Transporter 1, BIOMOLECULES, 12(4), 202204
  8. Expression and function of nicotinic acetylcholine receptors in induced regulatory T cells, International Journal of Molecular Sciences, 23, 1779, 2022
  9. Suppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophlic inflammation, ASIA PACIFIC ALLERGY, 11(3), 202107
  10. L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation, ASIA PACIFIC ALLERGY, 11(3), 202107
  11. Isoform-Selective NFAT Inhibitor: Potential Usefulness and Development, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(5), 202103
  12. Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of Action, PATHOGENS, 10(2), 202102
  13. Progress of genome editing technology and developmental biology useful for radiation research, Journal of Radiation Research, 62, i53-i63, 2021
  14. Sublingual immunotherapy: how sublingual allergen administration heals allergic diseases; current perspective about the mode of action, Pathogens, 10(2), 147, 2021
  15. Isoform-Selective NFAT Inhibitor: Potential Usefulness and Development, International Journal of Molecular Science, 22, 2725, 2021
  16. Suppressive effect of dexamethasone on murine Th9 cell-mediated nasal eosinophilic inflammation, Asia Pacific Allergy, 11, e25, 2021
  17. L-type amino acid transporter 1 inhibitor suppresses murine Th2 cell-mediated bronchial hyperresponsiveness independently of eosinophil accumulation, Asia Pacific Allergy, 11, e33, 202107
  18. Role of CD4(+) T Cells in Allergic Airway Diseases: Learning from Murine Models, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21(20), 202010
  19. Identification of pyrogallol from Awa-tea as an anti-allergic compound that suppresses nasal symptoms and IL-9 gene expression, JOURNAL OF MEDICAL INVESTIGATION, 67(3-4), 289-297, 202008
  20. Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction, CLINICAL CANCER RESEARCH, 26(8), 2065-2079, 202004
  21. Suppressive effect of environmental tobacco smoke on murine Th2 cell-mediated nasal eosinophilic inflammation, ASIA PACIFIC ALLERGY, 10(2), 202004
  22. Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production, INTERNATIONAL IMMUNOLOGY, 32(3), 187-201, 202003
  23. LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation, ALLERGY, 75(2), 463-467, 202002
  24. Association of Basophil-Expressing Genes with Effectiveness of Sublingual Immunotheraphy, JOURNAL OF NIPPON MEDICAL SCHOOL, 87(1), 49-52, 202002
  25. Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells, FASEB JOURNAL, 34(2), 3197-3208, 202002
  26. T Cell-Mediated Nasal Hyperresponsiveness in Allergic Rhinitis, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 43(1), 36-40, 202001
  27. LAT1-specific inhibitor is effective against T cell-mediated allergic skin inflammation., Allergy, 75, 463-467, 2020
  28. Basophil-expressing genes related with the efficacy of sublingual immunotherapy., Journal of Nippon Medical School, 87(49-52), 2020
  29. T cell-mediated nasal hyperresponsiveness in allergic rhinitis., Biological and Pharmaceutical Bulletin, 43, 36-40, 2020
  30. Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production., International Immunology, 32, 187-201, 2020
  31. L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness., Allergology International, 69(3), 455-458, 2020
  32. Identification of novel interacting regions involving calcineurin and nuclear factor of activated T cells., FASEB Journal, 34, 3197-3208, 2020
  33. Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization and causes bladder cancer in cooperation with p53 dysfunction., Clinical Cancer Research, 26(8), 2065-2079, 2020
  34. Suppressive effect of environmental tobacco smoke on murine Th2 cell-mediated nasal eosinophilic inflammation, Asia Pacific Allergy, 10(2), e18, 2020
  35. Epicutaneous allergen administration without antigen delivery device induces local T cell response and alleviates food allergic enteropathy., Allergology International, 69, 622-625, 2020
  36. Identification of pyrogallol from Awa-tea as an anti-allergic compound that suppresses nasal symptoms and IL-9 gene expression, Journal of Medical Investigation, 67(3-4), 289-297, 2020
  37. Role of CD4+ T Cells in Allergic Airway Diseases: Learning from Murine Models, International Journal of Molecular Science, 21(20), 7480, 2020
  38. Thrombospondin 1-mediated suppression of mast cell degranulation is involved in the efficacy of sublingual immunotherapy., Allergology International, 68, S9-10, 2019
  39. Potential Mechanisms of T Cell-Mediated and Eosinophil-Independent Bronchial Hyperresponsiveness., International Journal of Molecular Sciences, 20, 2980, 2019
  40. T-Helper Type 2 Cells Direct Antigen-Induced Eosinophilic Skin Inflammation in Mice., Allergy, asthma & immunology Research, 10, 77-82, 2018
  41. Down-regulation of NFAT3 due to lack of T-box transcription factor TBX5 is crucial for cytokine expression in T cells., Journal of Immunology, 200, 92-100, 2018
  42. Contribution of neuraminidase 3 to the differentiation of induced regulatory T cells., Genes to Cells, 23, 112-116, 2018
  43. Involvement of taste receptors in the effectiveness of sublingual immunotherapy., Allergology International, 67, 421-424, 2018
  44. Effects of anti-allergic drugs on T cell-mediated nasal hyperresponsiveness in a murine model of allergic rhinitis., Allergology International, 67, S25-31, 2018
  45. Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis., Allergy, Asthma & Immunology Research, 10, 562-569, 2018
  46. Serum Cytokine Interactions Are Implicated in the Mechanism of Action of Sublingual Immunotherapy for Japanese Cedar Pollinosis., Journal of Nippon Medical School, 85, 250-258, 2018
  47. Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA., Journal of Autoimmunity, 80, 28-38, 2017
  48. ★, Hyper-reactive cloned mice generated by direct nuclear transfer of antigen-specific CD4+ T cells., EMBO Reports, 18, 885-893, 2017
  49. Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis., International Immunology, 29, 291-300, 2017
  50. Th9 cells induce steroid-resistant bronchial hyperresponsiveness in mice., Allergol International, 66, S35-40, 2017
  51. Oral administration of ovalbumin after sensitization attenuate symptoms in a mouse model of food allergic enteropathy., Bioscience, Biotechnology, and Biochemistry, 81, 1901-1972, 2017
  52. Differential Contribution of Adhesion Molecules to Th1 and Th2 Cell-Mediated Lung and Bowel Inflammation., Biological & Pharmaceutical Bulletin, 40, 1081-1805, 2017
  53. Essential Contribution of CD4+ T Cells to Antigen-Induced Nasal Hyperresponsiveness in Experimental Allergic Rhinitis., PloS One, 11, e0146686, 2016
  54. Induced Treg Cells Augment the Th17-Mediated Intestinal Inflammatory Response in a CTLA4-Dependent Manner., PloS One, 11, e0150244, 2016
  55. Critical role of CD44 in antigen-induced Th2- but not Th17-mediated murine airway inflammation., Allergology International, 65, S59-61, 2016
  56. Th9 cells elicit eosinophil-independent bronchial hyperresponsiveness in mice., Allergology International, 65, S24-29, 2016
  57. Crosstalk between histamine and T cells in allergic diseases., Curr Immunol Rev, 2016
  58. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)., Journal of Clinical Immunology, 35, 661-667, 2015
  59. Selective suppression of Th2 cell-mediated lung eosinophilic inflammation by anti-major facilitator super family domain containing 10 monoclonal antibody., Allergology International, 63, S29-35, 2014
  60. Antigen-induced mixed and separated inflammation in murine upper and lower airways., Allergology International, 63, S59-61, 2014
  61. Food Allergen-induced IgE Response Mouse Model Created by Injection of in vitro Differentiated Th2 Cell Culture and Oral Antigen Intake., Bioscience of Microbiota, Food and Health, 33, 41-46, 2014
  62. IL-17A induces hypo-contraction of intestinal smooth muscle via induction of iNOS in muscularis macrophages., Journal of Pharmacological Sciences, 125, 394-405, 2014
  63. Transgenic plants for allergen-specific immunotherapy., World J Immunol, 4, 141-148, 2014
  64. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis., Plant Biotechnology Journal, 11, 66-76, 2013
  65. Identification of Acyl-CoA thioesterase in mouse mesenteric lymph nodes., Biological & Pharmaceutical Bulletin, 36, 866-871, 2013
  66. A contraction assay system using primary cultured mouse bronchial smooth muscle cells., International Archives of Allergy and Immunology, 161, S93-97, 2013
  67. Existence of antigen-specific IgE is not sufficient for allergic nasal eosinophil infiltration in mice., International Archives of Allergy and Immunology, 161, S125-128, 2013
  68. Oral immunotherapy for allergic diseases using transgenic rice seeds: current state and future prospects., International Archives of Allergy and Immunology, 161, S164-169, 2013
  69. Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4., Clinical and Experimental Allergy, 42, 315-325, 2012
  70. Murine T cell-derived contractile activity for bronchial smooth muscle cells., International Archives of Allergy and Immunology, 158, S7-10, 2012
  71. NFAT1 and NFAT2 differentially regulate IL-17A expression in human T cells., International Archives of Allergy and Immunology, 158, S30-34, 2012
  72. Inhibition of allergen-induced airway inflammation by low-dose oral immunotherapy with transgenic rice seeds independently of immunoglobulin e synthesis., International Archives of Allergy and Immunology, 158, S66-69, 2012
  73. Protein phosphatase 1 is involved in IL-2-induced IL-5 and IL-13 expression in human T cells., Genes to Cells, 17, 611-618, 2012
  74. Establishment of monoclonal antibodies against a novel eosinophil-specific cell surface molecule, major facilitator super family domain containing 10., Immunology Letters, 147, 80-84, 2012
  75. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression., Plant Biotechnology Journal, 9, 982-990, 2011
  76. Zinc finger protein, multitype 1 suppresses human Th2 development via downregulation of IL-4., International Archives of Allergy and Immunology, 155, S53-56, 2011
  77. Comparative analysis of steroid sensitivity of Th cells in vitro and in vivo., International Archives of Allergy and Immunology, 155, S110-116, 2011
  78. CD44 is critical for airway accumulation of antigen-specific Th2, but not Th1, cells induced by antigen challenge in mice., European Journal of Immunology, 41, 3198-3207, 2011
  79. Vaccination with transgenic rice seed expressing mite allergen: a new option for asthma sufferers?, Expert Review of Vaccines, 10, 1249-1251, 2011
  80. Selective down-regulation of Th2 cytokines by C-terminal binding protein 2 in human T cells., International Archives of Allergy and Immunology, 152, S18-21, 2010
  81. Effect of sublingual immunotherapy on antigen-induced bronchial and nasal inflammation in mice., International Archives of Allergy and Immunology, 152, S75-78, 2010
  82. Eosinophils are required for the induction of bronchial hyperresponsiveness in a Th-transfer model of Balb/c background., International Archives of Allergy and Immunology, 152, S79-82, 2010
  83. Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition., The Journal of Investigative Dermatology, 130, 2760-2767, 2010
  84. Suppressive role of C-terminal binding protein 1 in IL-4 synthesis in human T cells., Biochemical and Biophysical Research Communications, 382, 326-330, 2009
  85. T-box 21 transcription factor is responsible for distorted TH2 differentiation in human peripheral CD4+ T cells., The Journal of Allergy and Clinical Immunology, 123, 813-823, 2009
  86. Regulation of DNA demethylation during maturation of CD4+ naive T cells by the conserved noncoding sequence 1., Journal of Immunology, 182, 7698-7707, 2009
  87. Murine Th clones confer late asthmatic response upon antigen challenge., International Archives of Allergy and Immunology, 149, S2-6, 2009
  88. Development of transgenic rice expressing mite antigen for a new concept of immunotherapy., International Archives of Allergy and Immunology, 149, S21-24, 2009
  89. Proteomic Approach to FcepsilonRI aggregation-initiated signal transduction cascade in human mast cells., International Archives of Allergy and Immunology, 149, S73-76, 2009
  90. Evaluation of cysteinyl leukotriene-induced contraction of human cultured bronchial smooth muscle cells., International Archives of Allergy and Immunology, 149, S83-86, 2009
  91. Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells., Journal of Immunology, 180, 319-326, 2008
  92. Selective inhibitors of nuclear factor of activated T cells: potential therapeutic drugs for the treatment of immunological and inflammatory diseases., Inflammation & Allergy Drug Targets, 7, 35-40, 2008
  93. Airway eosinophilic inflammation is attenuated in conserved noncoding sequence-1 deficient mice., International Archives of Allergy and Immunology, 146, S2-6, 2008
  94. Downregulation of IL-13 gene transcription by T-bet in human T cells., International Archives of Allergy and Immunology, 146, S33-35, 2008
  95. A contraction assay system using established human bronchial smooth muscle cells., International Archives of Allergy and Immunology, 146, S36-39, 2008
  96. IL-4 gene transcription in human T cells is suppressed by T-bet., International Archives of Allergy and Immunology, 143, S68-70, 2007
  97. IL-9 production by peripheral blood mononuclear cells of atopic asthmatics., International Archives of Allergy and Immunology, 143, S76-79, 2007
  98. Effect of formoterol on allergen-induced cytokine synthesis by atopic asthmatics., International Archives of Allergy and Immunology, 143, S106-109, 2007
  99. Selective suppression of Th2 cell-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonists., International Immunology, 19, 913-921, 2007
  100. Functional chemokine receptors in allergic diseases: is CCR8 a novel therapeutic target?, Mini Reviews in Medicinal Chemistry, 6, 463-466, 2006
  101. Characterization of binding activity between nuclear factor of activated T cells and calcineurin by amplified luminescent proximity homogeneous assay., Journal of Immunological Methods, 312, 105-110, 2006
  102. IL-2-induced IL-13 production by allergen-specific human helper T cell clones., International Archives of Allergy and Immunology, 140, S51-54, 2006
  103. Th2 cell-mediated chemokine synthesis is involved in allergic airway inflammation in mice., International Archives of Allergy and Immunology, 140, S55-58, 2006
  104. Genetic factors in the treatment of bronchial asthma., Expert Review of Clinical Immunology, 2, 727-735, 2006
  105. Role of GATA-3 in IL-5 gene transcription by CD4+ T cells of asthmatic patients., International Archives of Allergy and Immunology, 137, S55-59, 2005
  106. Correlation between mRNA expression in Th1/Th2 cytokines and their specific transcription factors in human helper T cell clones., Immunology and Cell Biology, 83, 536-541, 2005
  107. GATA-3 suppresses IFN-gamma promoter activity independently of binding to cis-regulatory elements., FEBS Letters, 570, 63-68, 2004
  108. Interaction with monocytes enhances IL-5 gene transcription in peripheral T cells of asthmatic patients., International Archives of Allergy and Immunology, 131, S20-25, 2003
  109. Vav-induced activation of the human IFN-gamma gene promoter is mediated by upregulation of AP-1 activity., FEBS Letters, 514, 153-158, 2002
  110. Transient contribution of mast cells to pulmonary eosinophilia but not to hyperresponsiveness., Clinical and Experimental Allergy, 32, 475-483, 2002
  111. Potential initiation of eosinophilic skin inflammation by antigen-specific T helper type 2 cells., International Archives of Allergy and Immunology, 128, S21-23, 2002
  112. Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors., Clinical and Experimental Immunology, 128, 460-466, 2002
  113. Transcriptional regulation of the IL-5 gene in peripheral T cells of asthmatic patients., Clinical and Experimental Immunology, 130, 475-483, 2002
  114. Correlation between eosinophilia induced by CD4+ T cells and bronchial hyperesponseiveness., International Immunology, 13, 329-339, 2001
  115. Vav/Rac1-mediated activation of the JNK/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the IL-2 gene promoter., Molecular and Cellular Biology, 21, 3126-3136, 2001
  116. Humoral immunity is dispensable for the local recruitment of antigen-specific Th2 cells., International Archives of Allergy and Immunology, 125, S17-18, 2001
  117. Dynamics of antigen-specific helper T cells at the initiation of airway eosinophilic inflammation., European Journal of Immunology, 31, 2669-2679, 2001
  118. IL-5 synthesis by T cells of allergic subjects is regulated at the transcriptional level., International Archives of Allergy and Immunology, 122, S63-66, 2000
  119. Control of interleukin-5 production by human helper T cells as a treatment for eosinophilic inflammation: Comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors., The Journal of Allergy and Clinical Immunology, 106, S58-64, 2000
  120. Transcriptional regulation of IL-5 gene by nontransformed human T cells through the proximal promoter element., Internal Medicine, 39, 618-625, 2000
  121. Cloned Th cells confer eosinophilic inflammation and bronchial hyperresponsiveness., International Archives of Allergy and Immunology, 118, 136-139, 1999
  122. Regulatory mechanisms of human T cell IL-5 synthesis: differential roles of the proximal promoter-binding proteins in IL-5 gene transcription., International Archives of Allergy and Immunology, 118, 271-274, 1999
  123. Transcriptional control of IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis., The Journal of Allergy and Clinical Immunology, 103, S429-436, 1999
  124. Cyclic AMP suppresses interleukin-5 synthesis by human helper T cells via the downregulation of the calcium mobilization pathway., British Journal of Pharmacology, 127, 521-529, 1999
  125. p38 MAP kinase regulates human T cell IL-5 synthesis., Journal of Immunology, 163, 4763-4771, 1999
  126. Primary role of CD4+ T cells and supplemental role of mast cells in allergic pulmonary eosinophilia., International Archives of Allergy and Immunology, 120, S15-18, 1999
  127. A selective type 4 phosphodiesterase inhibitor, T-440, modulates intracellular cAMP level and interleukin-2 production of Jurkat cells., Immunopharmacology, 38, 247-252, 1998
  128. A novel anti-allergic drug, betotastine besilate, suppresses interleukin-5 production by human peripheral blood mononuclear cells., Biological & Pharmaceutical Bulletin, 21, 411-413, 1998
  129. Evidence that cyclosporin A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 synthesis by T cells., British Journal of Pharmacology, 124, 1425-1432, 1998
  130. IL-5-producing T cells that induce airway eosinophilia and hyperresponsiveness are suppressed by dexamethasone and cyclosporin A in mice., International Archives of Allergy and Immunology, 117, S24-27, 1998
  131. Prevention of ozone-induced airway hyperresponsiveness and epithelial injury by phosphodiesterase inhibitors in guinea pigs., Environmental Toxicology and Pharmacology, 3, 201-209, 1997
  132. IL-2-induced IL-5 synthesis, but not proliferation, of human CD4+ T cells is suppressed by FK506., Journal of Immunology, 158, 3659-3665, 1997
  133. Effect of T-440, a novel type IV phosphodiesterase inhibitor, on allergen-induced immediate and late asthmatic reaction and leukocyte infiltration into the airways of guinea pigs., International Archives of Allergy and Immunology, 112, 406-411, 1997
  134. Two distinct pathways of IL-5 synthesis in allergen-specific human T cell clones are suppressed by glucocorticoids., Blood, 89, 2891-2900, 1997
  135. Successful transfer of late phase eosinophil infiltration in the lung by infusion of helper T cell clones., American Journal of Respiratory Cell and Molecular Biology, 16, 448-454, 1997
  136. Dissection of human IL-5 promoter--essential role of CLEO element in human IL-5 gene transcription., International Archives of Allergy and Immunology, 113, 272-274, 1997
  137. Selective suppression of IL-5 synthesis by OM-01--pinpoint treatment of atopic diseases by IL-5 gene transcription inhibitor., International Archives of Allergy and Immunology, 113, 331-334, 1997
  138. Two differential effects of cyclic AMP on IL-5 production by antigen-specific human T cell line., The Journal of Pharmacology and Experimental Therapeutics, 283, 345-349, 1997
  139. Development of lung eosinophilic inflammation by the infusion of IL-5-producing T cell clones., International Archives of Allergy and Immunology, 114, S10-13, 1997
  140. Control of allergic diseases by regulation of cytokine gene transcription., Arbeiten aus dem Paul-Ehrlich-Institut zu Frankfurt A.M, 91, 209-221, 1997
  141. Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness., European Journal of Pharmacology, 337, 259-265, 1997
  142. Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: A study with allergen—specific human helper T cells., The Journal of Allergy and Clinical Immunology, 100, S56-64, 1997
  143. Bronchial anti-spasmogenic effects and its selectivity of T-440, phosphodiesterase type 4 inhibitor, in the dog., Biological & Pharmaceutical Bulletin, 20, 1261-1265, 1997
  144. Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans., Journal of Medicinal Chemistry, 39, 2696-2704, 1996
  145. IL-15 promotes cytokine production of human T helper cells., Journal of Immunology, 156, 2400-2405, 1996
  146. Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: relation to phosphodiesterase inhibition., The Journal of Pharmacology and Experimental Therapeutics, 279, 240-246, 1996
  147. Inhibitory effect of a novel phosphodiesterase IV inhibitor, T-440 on antigen- and chemical mediator-induced bronchoconstrictions in guinea pigs in vivo., Japanese Journal of Pharmacology, 72, 1-8, 1996
  148. A novel phosphodiesterase inhibitor, T-440; possible management of eosinophilic inflammation by down-regulation of Interleukin-5 production., International Archives of Allergy and Immunology, 111, S16-18, 1996
  149. A critical role of IL-2 for the production and gene transcription of IL-5 in allergen-specific human T cell clones., International Immunology, 8, 1889-1895, 1996
  150. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A., International Immunology, 7, 449-457, 1995
  151. Allergen-specific human T cell clones produce interleukin-5 upon stimulation with the Th1 cytokine interleukin-2., International Archives of Allergy and Immunology, 107, 220-222, 1995
  152. Analysis of human interleukin-5 gene transcription by T cell clones and hybridomas., International Archives of Allergy and Immunology, 107(1-3), 1995
  153. Importance of impairment of the airway epithelium for ozone-induced airway hyperresponsiveness in guinea pigs., Japanese Journal of Pharmacology, 67, 375-382, 1995
  154. Difference among angiotensin-converting enzyme inhibitors in potentiating effects on bradykinin-induced microvascular leakage in guinea pig airways., Japanese Journal of Pharmacology, 69, 111-118, 1995
  155. Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid., International Archives of Allergy and Immunology, 104, S32-35, 1994
  156. Reflex activities of the upper airway muscles during experimental nasal occlusion in anesthetized dogs., The Journal of Veterinary Medical Science, 53, 93-99, 1991

Publications such as books

  1. 2004, Immunology 2004, Comparative analysis for calcineurin binding activity of NFAT family members., Medimond International Proceedings, 2004
  2. 1996, New Horizons in Allergy and Immunotherapy, Enhanced production and gene expression of IL-5 in bronchial asthma: Possible management of atopic diseases with IL-5 specific gene transcription inhibitor., Plenum Publishing Corporation, 1996

Social Activities

History as Committee Members

  1. Editor, Experimental Animals, 2018/04, 2023/03
  2. Editor, Experimental Animals, 2018/04, 2023/03
  3. Editor, Translational and Regulatory Sciences, 2019/08, 2023/03
  4. Editor, Translational and Regulatory Sciences, 2019/08, 2023/03
  5. Editor, Internatinal Journal of Moleculer Science, 2020/10, 2023/03
  6. Editor, Internatinal Journal of Moleculer Science, 2020/10, 2023/03